CAS No. 927961-18-0
Batch:
Purity:99.59
Chemical Structure
Check the
Lanifibranor (IVA-337)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloroindol-2-yl]butanoic acid | |
|---|---|---|
| CAS Number | 927961-18-0 | |
| Molecular Formula |
C19H15ClN2O4S2 |
|
| Molecular Weight (MW) | 434.92 | |
| SMILES | C1=CC2=C(C=C1S(=O)(=O)N3C4=C(C=C(C=C4)Cl)C=C3CCCC(=O)O)SC=N2 | |
| InChIKey | OQDQIFQRNZIEEJ-UHFFFAOYSA-N |
Lanifibranor (IVA-337) is a pan-peroxisome proliferator-activated receptor (PPAR) agonist that activates hPPARα (EC50 1537 nM), hPPARδ (EC50 866 nM), and hPPARγ (EC50 206 nM). By activating all three PPAR isoforms, it regulates gene expression involved in lipid metabolism, inflammation, and tissue remodeling. This balanced activation inhibits pro-fibrotic signaling pathways, reduces collagen synthesis, and exerts potent anti-inflammatory and anti-fibrotic effects in preclinical models.
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
87 mg/mL
(200.03 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
87 mg/mL
(200.03 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
87 mg/mL
(200.03 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Lanifibranor (IVA-337) Mechanism of Action: Pan-PPAR Activation in Hepatocytes Research
- Lanifibranor (IVA-337) Clinical Trials
- Lanifibranor (IVA-337) Solubility in DMSO
- Lanifibranor (IVA-337) Stock Solution
- Lanifibranor (IVA-337) Storage
- Lanifibranor (IVA-337) Stability
- Lanifibranor (IVA-337) Molecular Weight
- Lanifibranor (IVA-337) SMILES
- Lanifibranor (IVA-337) Chemical Structure (2D and 3D)
- Lanifibranor (IVA-337) Cayman (25572)? Try a better option.
- Lanifibranor (IVA-337) Sigma (BL3H1F1CDA0C)? Try a better option.
- Lanifibranor (IVA-337) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.